Abstract
Introduction: The coronavirus (COVID-19) pandemic presented significant challenges to the management of breast cancer patients. Immunosuppression from chemotherapy increases risk of COVID-19 related complications and mortality. Balancing patient safety and service provision required careful assessment. ABS released guidelines on how services should adapt. This audit aimed to assess how well guidelines were adhered to and evaluate patient outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
